The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Pertuzumab/trastuzumab
Australian Public Assessment Report
Device/Product Name
Phesgo SC
Active ingredients
Pertuzumab/trastuzumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01326-1-4
Submission Type
New combination of active ingredients
Decision
Approved